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citation index has not significantly increased (p=0.14) but, after adjustment for impact
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STARD. Adherence to STARD should be mandatory for authors of diagnostic accuracy
studies.
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the quality of the manuscript and hope that the manuscript is now acceptable for publication in this 
journal. 
 
This manuscript is not under consideration for publication elsewhere. None of the paper‟s contents 
have been previously published. All authors have read and approved the manuscript. There are no 
potential conflicts of interest for any of the authors.  
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RESPONSE 
We very much appreciate the reviewer’s ongoing input and his kind comments 
regarding the manuscript. We hope we have sufficiently addressed his 
suggestions below: 
1) Please consider whether you want to revise the result section as following: "? when compared to 
those that did not (81.2 ±9.3% vs. 74.3 ± 12.7%, respectively; p=0.06). However, after 
adjusting for potential confounder including impact factor and year of publication, this difference 
attenuated (p=0.72)." 
We thank the reviewer for suggesting clearer articulation and have adjusted the body of text 
accordingly: “However, after adjusting for the potential confounder impact factor and year of 
publication, this difference attenuated (p=0.72)." 
 
2) I guess there are also some typos in the results section. Without having the actual stats 
printouts, is this version correct?  "?before the introduction of STARD (estimate: -0.018, 
p=0.97). However, during the 8 years after the introduction of STARD, the model suggests an 
increase in adherence to STARD criteria by 1.46% (sum of estimates: -0.018+1.479=1.461, 
p=0.04) for each calendar year (Figure 2)." 
The confusion and discrepancy is likely due to rounding issues. To make it clearer we rounded 
to the same number of decimals and have adjusted our manuscript accordingly. “After 
controlling for the potential confounder impact factor, reporting quality remained unchanged in the 8 years 
before the introduction of STARD (estimate -0.018, p=0.97). However, during the 8 years after the 
introduction of STARD, the model suggests an increase in adherence to STARD criteria by 1.461% (sum of 
estimates -0.018 +1.479, p=0.04) for each calendar year (Figure 2).” 
3) Please check again your way reporting p-values, particular in table 2. I strongly recommend to 
round all p-values >=0.01 to two decimal places (example 0.025 -> 0.03; 0.013 -> 0.01) and 
round p-values <0.01 to the first digit which is unequal to zero (example 0.0076 -> 0.008). 
Why is the p-value for criteria 3 comparing SPECT publications in the revised version now 0.029 
and in the original version 0.048? 
We have adjusted the p values as recommended throughout the manuscript. We thank the reviewer 
for identifying the discrepancy regarding criteria 3 in table 2 – this figure appears to be the result 
of a typographical error that occurred during the recalculation of p values to discern decimal places. 
The original figure of p=0.048 is correct and has been reinstated and rounded to p=0.05 as 
recommended. All other p values that were recalculated have been rechecked and remain as 
written. 
4) Please correct the scaling of the x-axis of Figure 2 a and b that they are identical 
We have redone both Figures 2a and 2b and ensured they have same x-axis, including scaling 
and font sizes and symbol shapes and reference line types. 
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ABSTRACT  
Aims: Diagnostic accuracy studies determine the clinical value of non-invasive cardiac imaging tests. The 
‘Standards for the reporting of diagnostic accuracy studies’ (STARD) were published in 2003 to improve the 
quality of study reporting. We aimed to assess the reporting quality of cardiac computed tomography (CCT), 
single positron emission computed tomography (SPECT) and cardiac magnetic resonance (CMR) diagnostic 
accuracy studies; to evaluate the impact of STARD; and to investigate the relationships between reporting 
quality, journal impact factor and study citation index. 
Methods and Results: We randomly generated 6 groups of 50 diagnostic accuracy studies: ‘CMR 1995-2002’, 
‘CMR 2004-2011’, ‘CCT 1995-2002’, ‘CCT 2004-2011’, ‘SPECT 1995-2002’, and ‘SPECT 2004-2011’. The 
300 studies were double-read by 2 blinded reviewers and reporting quality determined by % adherence to the 25 
STARD criteria. Reporting quality increased from 65.3% before STARD to 74.1% after (p=0.003) in CMR 
studies and from 61.6% to 79.0% (p<0.001) in CCT studies. SPECT studies showed no significant change: 
71.9% before and 71.5% after STARD (p=0.92). Journals advising authors to refer to STARD had significantly 
higher impact factors than those that did not (p=0.03), and journals with above-median impact factors published 
studies of significantly higher reporting quality (p<0.001). Since STARD, citation index has not significantly 
increased (p=0.14) but, after adjustment for impact factor, reporting quality continues to increase by 
approximately 1.5% each year. 
Conclusion: Reporting standards for diagnostic accuracy studies of non-invasive cardiac imaging are at most 
satisfactory and have improved since the introduction of STARD. Adherence to STARD should be mandatory 
for authors of diagnostic accuracy studies. 
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ABSTRACT  
Aims: Diagnostic accuracy studies determine the clinical value of non-invasive cardiac imaging tests. The 
‘Standards for the reporting of diagnostic accuracy studies’ (STARD) were published in 2003 to improve the 
quality of study reporting. We aimed to assess the reporting quality of cardiac computed tomography (CCT), 
single positron emission computed tomography (SPECT) and cardiac magnetic resonance (CMR) diagnostic 
accuracy studies; to evaluate the impact of STARD; and to investigate the relationships between reporting 
quality, journal impact factor and study citation index. 
Methods and Results: We randomly generated 6 groups of 50 diagnostic accuracy studies: ‘CMR 1995-2002’, 
‘CMR 2004-2011’, ‘CCT 1995-2002’, ‘CCT 2004-2011’, ‘SPECT 1995-2002’, and ‘SPECT 2004-2011’. The 
300 studies were double-read by 2 blinded reviewers and reporting quality determined by % adherence to the 25 
STARD criteria. Reporting quality increased from 65.3% before STARD to 74.1% after (p=0.003) in CMR 
studies and from 61.6% to 79.0% (p<0.001) in CCT studies. SPECT studies showed no significant change: 
71.9% before and 71.5% after STARD (p=0.922). Journals advising authors to refer to STARD had significantly 
higher impact factors than those that did not (p=0.02503), and journals with above-median impact factors 
published studies of significantly higher reporting quality (p<0.001). Since STARD, citation index has not 
significantly increased (p=0.13914) but, after adjustment for impact factor, reporting quality continues to 
increase by approximately 1.5% each year. 
Conclusion: Reporting standards for diagnostic accuracy studies of non-invasive cardiac imaging are at most 
satisfactory and have improved since the introduction of STARD. Adherence to STARD should be mandatory 
for authors of diagnostic accuracy studies. 
 
KEYWORDS 
Diagnostic accuracy, STARD, reporting quality 
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ABBREVIATIONS LIST 
CMR, cardiac magnetic resonance;  
CCT, cardiac computed tomography;  
SPECT, single positron emission computed tomography;  
STARD, Standards for the reporting of diagnostic accuracy studies;  
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INTRODUCTION 
Advanced non-invasive cardiovascular imaging modalities, such as Cardiovascular Magnetic 
Resonance (CMR) imaging, Cardiovascular Computed Tomography (CCT) and Single Positron 
Emission Computed Tomography (SPECT) are increasingly requested clinically. Between 2000 and 
2006, Medicare expenditure on medical imaging increased annually by 17% and, since 1996, mean per 
capita radiation dose has doubled, highlighting the need to avoid unnecessary use of these expensive 
technologies 
(1, 2)
.  
Diagnostic accuracy is an important consideration in determining the cost-effectiveness of an imaging 
test, but often varies amongst different publications. This may reflect the dependence of the results on 
factors such as study design, patient population and technical considerations as well as random 
variability. Insufficient reporting may not allow assessment of the internal and external validity of the 
study findings. Furthermore, over-optimistic diagnostic accuracy results can lead to the premature 
dissemination of imaging tests and consequently to doctors making incorrect management decisions, 
contributing to the significant rise in health care costs.  
In 2003, the Standards for the Reporting of Diagnostic Accuracy Studies (STARD) group published a 
set of 25 criteria with the objective of improving the reporting quality of diagnostic accuracy studies 
(3-
5)
.
 
These criteria allow the reader to identify the potential for bias in the study (internal validity) and to 
evaluate whether the results of the studies can be generalized to a wider population (external validity). 
To date, over 200 journals advise authors to refer to STARD when submitting manuscripts 
(http://www.stard-statement.org/). 
Given the importance of high quality diagnostic test reporting in cardiac patients and the lack of data 
on adherence to the STARD criteria in this field, the aim of this study was to assess the impact of 
STARD by comparing the reporting quality of CCT, SPECT and CMR studies published in the eight 
years before STARD (1995-2002) with those published in the eight years after (2004-2011). 
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METHODS 
Literature Search 
A literature search of the Ovid Medline and EMBASE databases was performed on September 1
st
 
2011. We searched for CCT, SPECT and CMR studies of diagnostic accuracy published before (1995-
2002 inclusive) and after (2004-2011 inclusive) the introduction of the STARD statement in 2003. The 
MeSH terms, corresponding number of identified studies and study groupings are shown in Figure 1. 
 
Selection Criteria 
We included studies that examined the performance of CCT, SPECT or CMR investigations in relation 
to a reference standard. Animal models, reviews, meta-analyses, and studies comparing more than one 
of the CCT, SPECT or CMR modalities against a reference standard were excluded. The identified 
studies were assigned to one of six groups: CCT, SPECT or CMR diagnostic accuracy studies 
published before and after the introduction of STARD in 2003, respectively. In each group, eligible 
studies were numbered and 50 papers selected for analysis using a random number generator 
(Microsoft Excel 2010, Microsoft). Data extraction was performed from each of the selected abstracts. 
Studies that did not meet the inclusion criteria during data extraction were excluded and replaced by 
studies using the random number generator until 50 studies were identified for each of the six groups.  
 
Scoring 
The 300 included studies were blinded to date, authorship, references and journal of publication, and 
read against the criteria of the STARD checklist. Reviewer 1 (E.M.) read all 300 studies; Reviewer 2 
(I.S.) read a random selection of 100 studies, and Reviewer 3 (F.C.) read the remaining 200 studies; 
both reviewers were blinded to the findings of Reviewer 1. Reviewer 4 (S.P.) resolved any disputed 
decisions. All four reviewers were provided with a document explaining the STARD statement and its 
rationale, and were instructed to refer to the STARD statement website (www.stard-statement.org) if 
further clarification on the criteria was required. A total of 7500 STARD items were evaluated within 
the 300 manuscripts. For each STARD criterion, reviewers assigned ‘Yes’ if the manuscript addressed 
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the item appropriately and ‘No’ if it did not. If a criterion was considered not applicable to the study, 
such as in retrospective studies where participant dropout does not occur, the abbreviation ‘NA’ was 
used.  
Impact Factor and Citation Index 
Impact factor in the year of study publication was sourced for each journal from the Thomson Reuters 
Web of Science database. Study Citation Index was calculated by counting the total number of citations 
in the two years following study publication according to Web of Science data. 
Statistics 
Reporting quality was assessed in all studies by calculating the percentage adherence to the STARD 
criteria by dividing the number of agreements with STARD criteria per study by the number of 
possible agreements (25 criteria minus number of criteria considered not applicable for specific study). 
We used the following formula: 
% Adherence =    Number of ‘Yes’       x 100 
 25 – Number of ‘NA’ 
 
Data were examined for normality (median and mean comparison, skewness, kurtosis, the Shapiro 
Wilks test and normal probability plots). Normally distributed data are presented as mean ± standard 
deviation and non-normally distributed data as median (interquartile range). We performed 
independent t-tests or ANOVA for normally distributed data and the Wilcoxon rank-sum test or 
Kruskal-Wallis test for independent samples that were not normally distributed. Chi-square tests were 
used to assess for differences in adherence to all individual STARD criteria. 
A linear regression model was built with adherence (%) to STARD criteria as the outcome and the 
timing of publication with regards to the advent of the STARD criteria in 2003 (before or after 
STARD) as a binary exposure and potential confounders (impact factor, citation index). A spline with a 
knot in the year of STARD publication was introduced to allow for a change in the slope. In all cases 
the significance level was set at p≤0.05 (two-sided). No adjustment for multiple testing was performed 
for pre-specified sub-analyses. All statistical analyses were performed using SAS software (Version 
9.3; SAS Institute Inc., Cary, NC, US). 
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RESULTS 
Study Selection 
As shown in Figure 1, 37 of the initial 300 studies met exclusion criteria and were replaced; 19 were 
animal studies, 8 were meta-analyses or reviews, 6 studies compared more than one imaging modality 
to a reference standard, and 4 studies did not examine diagnostic accuracy. Of the included studies, 167 
evaluated the diagnostic accuracy of CCT, SPECT or CMR with invasive coronary angiography as the 
reference standard; the remaining papers referred to echocardiography (n=38), established CMR, CCT 
or nuclear techniques (n=58), surgical findings, biopsy or histological analysis (n=15), blood tests 
(n=5) or a combination of these investigations (n=17). 8 studies (2.7%) included quantitative 
prognostic data. 
 
Adjudication quality of adherence to STARD 
98.5% of all STARD criteria were evaluated in agreement between the reviewers. Reviewer 4 resolved 
disagreements on 116 of the 7500 (1.5%) assessed items. This high rate of agreement is reflected in an 
unweighted kappa-value of 0.96 (95% confidence interval 0.96 to 0.97). 
 
General reporting quality in non-invasive cardiovascular imaging 
The global adherence to STARD for the 300 studies was 70.6 ± 14.1% and Table 1 shows adherence 
for each STARD criteria separately. STARD criteria were considered 'Not Applicable' in 45 of 7500 
(0.6%) assessed items. The journal impact factor in the year of publication and the citation index for all 
non-invasive cardiovascular imaging studies were 2.8 (1.8; 4.8) and 5.0 (1.0; 11.0), respectively.  
 
Reporting quality according to imaging modality and impact of STARD initiative  
The adherence (%) to STARD criteria across the six groups - CCT, SPECT and CMR before and after 
STARD introduction in 2003 - is presented for each criterion separately (Table 2) and for the combined 
criteria (Table 3).  
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The reporting quality increased from 65.3% to 74.1% (p=0.003) for CMR studies and from 61.6% to 
79.0% (p<0.001) for CCT studies following the introduction of STARD in 2003.  The SPECT studies, 
however, did not show any significant change in reporting quality: 71.9% before and 71.5% after 
STARD (p=0.92). Before the introduction of STARD, CCT studies had significantly poorer reporting 
standards compared to SPECT studies (p=0.001). After the introduction of STARD, CCT reporting 
standards were significantly higher than those of the SPECT studies (p=0.008). All other group 
comparisons did not show any significant difference in reporting quality (p>0.05 for all). 
 
Reporting quality according to journal’s author instructions, impact factors and citation indices 
Since 2003, papers from journals (13/150=8.7%) that advised authors to refer to the STARD guidelines 
demonstrated a trend of higher reporting quality when compared to those that did not (81.2 ±9.3% vs. 
74.3 ± 12.7%, respectively; p=0.06). However, after adjusting for the potential confounder impact 
factor and year of publication, this difference attenuated (p=0.72).However, journals that advised 
authors to comply with the STARD criteria did not have a greater increase in adherence to STARD 
compared with those journals that did not after adjusting for impact factor and year of publication 
(p=0.72). 
The impact factor of journals that have adopted STARD was significantly higher than those that have 
not (5.3 (3.7; 5.7) vs. 2.8 (2.1; 4.0), respectively; p=0.03). In journals whose impact factor was equal to 
or above the median, reporting standards were significantly higher than in journals with lower impact 
factors (Figure 3 – p<0.0001). We further investigated whether the impact factor benefited for journals 
that recommended adherence to STARD criteria. To this end, the null hypothesis that the slope or rate 
of change for the impact factor after publication of the STARD publication is the same for journals that 
recommended adherence to STARD criteria compared to those that did not could not be rejected, after 
adjusting for year of publication (p=0.15). 
The citation index for the two years following publication was similar between studies published 
before and after the STARD initiative (7.5 (5.0; 23.0) vs. 4.0 (2.0; 12.0) respectively; p=0.14). 
 
Formatted: Font: Times New Roman, 10 pt
 9 
Impact of the STARD initiative on reporting quality when controlling for confounders 
Our multivariable linear regression model allowed for a change in slope by introducing a knot in year 
2003 (STARD publication), which demonstrates the beneficial effect of the STARD criteria on the 
reporting standards of diagnostic accuracy studies. After controlling for the potential confounder 
impact factor, reporting quality remained unchanged in the 8 years before the introduction of STARD 
(estimate -0.0187, p=0.97). However, during the 8 years after the introduction of STARD, the model 
suggests an increase in adherence to STARD criteria by 1.461% (sum of estimates -0.018796 +1.479, 
p=0.04) for each calendar year (Figure 2). 
 
 DISCUSSION 
The important findings of this study are firstly that the reporting quality of studies investigating the 
diagnostic accuracy of CCT, SPECT and CMR techniques is at most satisfactory. Furthermore, since 
the publication of the STARD statement in 2003, reporting standards have significantly improved in 
studies of CCT and CMR but not SPECT.  Our assessment also shows that higher reporting quality is 
more strongly associated with a journal’s impact factor than with the journal mentioning the STARD 
criteria in the authors’ instructions, and that reporting quality does not correlate with citation index.  
Whilst similar reviews have been performed in fields such as Endoscopy 
(6)
 and Ophthalmology 
(7, 8)
, 
this is the first investigation into the standards of CCT, SPECT and CMR studies published both before 
and after the STARD statement. An overall average of 70.6% adherence to the STARD criteria 
compares favourably with findings from similar reviews of endoscopy (49%) (6), ophthalmology 
(50.3%) 
(7, 8)
 and gynaecology (55.1%) 
(9)
 journals.  
Previous reviews on the impact of the STARD statement itself have been mixed. Whilst Smidt et al. 
(2006) 
(10)
 reported a significant improvement in reporting standards across a sample of 265 articles 
from 12 medical journals, Wilczynski 
(11)
 did not find any meaningful improvement when comparing 
studies published before and after 2003, nor any difference between articles from journals that had 
adopted the STARD statement and those that had not. In our study, after adjustment for the confounder 
impact factor, the reporting standards measured by adherence to STARD criteria improved by an 
estimated mean of 1.5% per calendar year after the publication of the STARD statement.  
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We use adherence to the STARD statement as the sole measure of reporting quality, although the 25 
criteria are not all-encompassing; for example, they make no stipulation of minimum sample size and 
only require a discussion of the clinical applicability of the study findings. However, they are 
specifically tailored to diagnostic accuracy studies and we believe should be considered the gold 
standard for reporting quality in this study type. Even so, in Hirst & Altman’s  (12) review of 116 
journals, only 19 (16.4%) referred to reporting guidelines in their online instructions for authors, and 
we found that only 8.7% advised reference to STARD when submitting diagnostic accuracy studies. 
Our study suggests that reporting quality improves with this requirement.  
The finding that reporting standards have improved in CCT and CMR studies but not in those of 
SPECT is intriguing. This may be because, prior to STARD, CCT and CMR studies were 
predominantly developmental in nature and have since progressed to the validation phase. SPECT, 
meanwhile, is longer established and its use, together with other nuclear techniques, is declining by 3% 
annually in the United States 
(2)
. One could also speculate that, as CCT and CMR are younger imaging 
modalities, the researchers publishing in these areas are more willing to adapt to new reporting 
guidelines. 
Given the potentially serious consequences of poor diagnostic studies on patient management and 
healthcare costs, reporting standards remain a concern despite the clear improvement seen following 
publication of the STARD statement. The reporting of individual criteria varied from 28-98% , with 
seven criteria addressed in less than 50% of studies. Only 33% of studies made estimations of test 
reproducibility, which echoes that of similar reviews 
(8)
.This is likely attributable to the considerable 
resources required to perform such measurements and many authors choose to publish separate studies 
of reproducibility. However, the ability of a diagnostic test to deliver reproducible results is paramount, 
and every effort should be made to provide or reference such data where feasible. A quantification of 
observers’ training was found in only 28% of studies; this may seem a stringent requirement but, in 
practice, clinicians often consider an observer’s expertise when evaluating their opinion, and so such 
information should be made available to study readers as it informs generalizability of the study 
findings. Only 44% of studies mentioned adverse events; one might presume this reflects the relative 
safety of CCT, SPECT and CMR techniques over their invasive counterparts, but clarification of the 
absence of any complications is still necessary.  
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Strategies to further improve reporting standards may include journals not only advising reference to 
the STARD criteria in their author instructions, but making adherence to STARD a mandatory 
prerequisite to manuscript submission. In addition, the publication of systematic reviews such as this 
may further increase awareness of the STARD criteria and the importance of adhering to them. 
Although the selection of 300 studies constitutes less than 10% of the total identified literature, our 
selection and randomisation process should have ensured a representative sample of diagnostic 
accuracy manuscripts. As we did not adjust for multiple testing, there is a chance of reporting false 
positive findings. However, we pre-specified the assessment of the impact of the STARD 
recommendations on the quality of reporting as our primary hypothesis. We were surprised by the large 
disparity in the number of studies identified before and after 2003, but this could be attributed to the 
increased volume of studies published. Having used “diagnostic accuracy” as a search term, there is 
potential for a selection bias. The decision to include a small number of prognostic studies (n=8) must 
also be justified; the STARD statement refers to diagnostic accuracy studies alone, however, we 
believe the criteria are equally applicable to prognostic studies investigating quantitative outcome 
variables – such as degree of residual mitral regurgitation – where an account of technical 
specifications, statistical models, time intervals, participant recruitment and demographics, dropout and 
outliers remains essential. 
The reporting standards of diagnostic accuracy studies in the field of non-invasive cardiac imaging are 
satisfactory at best and have improved since the introduction of STARD. Those journals that advise 
authors to refer to STARD have significantly higher impact factors, and authors should be encouraged 
that journals of relatively high impact factors publish diagnostic accuracy studies of higher reporting 
quality. To further increase the adherence to the STARD criteria and thereby improve the quality of 
diagnostic accuracy studies, we suggest that more journals incorporate the STARD statement as a 
mandatory component of their submission process. By improving the transparency and completeness of 
study reporting, such measures may expedite the development of non-invasive imaging tests, reduce 
unnecessary expenditure and assist doctors in making evidence-based management decisions. 
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Table 1. 
STARD  
CRITERIA 
Number of studies 
that met criteria 
Number of studies 
that did not meet 
criteria 
Number of studies 
where criteria not 
applicable 
ADHERENCE 
(%) 
(n=300) 
Describe technical 
specifications of material and 
methods involved including 
how and when measurements 
were taken, and/or cite 
references for index tests and 
reference standard. 295 5 0 98 
State the research questions 
or study aims, such as 
estimating diagnostic 
accuracy or comparing 
accuracy between tests or 
across participant groups. 290 10 0 97 
Describe definition of and 
rationale for the units, cut-offs 
and/or categories of the results 
of the index tests and the 
reference standard. 286 14 0 95 
Discuss the clinical 
applicability of the study 
findings. 286 14 0 95 
Describe participant 
recruitment: Was recruitment 
based on presenting 
symptoms, results from 
previous tests, or the fact that 
the participants had received 
the (evaluated) index tests or 
the (golden) reference 
standard? 285 15 0 95 
Describe the reference 
standard and its rationale. 272 28 0 91 
Report estimates of diagnostic 
accuracy and measures of 
statistical uncertainty (e.g. 
95% confidence intervals). 259 41 0 86 
Describe data collection: 
Was data collection planned 
before the index test and 
reference standard were 
performed (prospective 
study) or after (retrospective 
study)? 256 43 1 85 
Report distribution of severity 
of disease (define criteria) in 
those with the target 
condition; other diagnoses in 
participants without the target 
condition. 256 44 0 85 
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Describe the study 
population: The inclusion 
and exclusion criteria, 
setting and locations where 
the data were collected. 249 51 0 83 
Describe methods for 
calculating or comparing 
measures of diagnostic 
accuracy, and the statistical 
methods used to quantify 
uncertainty (e.g. 95% 
confidence intervals). 247 53 0 82 
Describe participant 
sampling: Was the study 
population a consecutive 
series of participants defined 
by the selection criteria in 
items 3 and 4? If not, specify 
how participants were 
further selected. 237 61 2 79 
Describe whether or not the 
readers of the index tests and 
reference standard were blind 
(masked) to the results of the 
other test and describe any 
other clinical information 
available to the readers. 230 68 2 77 
Report a cross tabulation of 
the results of the index tests 
(including indeterminate 
and missing results) by the 
results of the reference 
standard; for continuous 
results, the distribution of 
the test results by the results 
of the reference standard. 226 73 1 75 
Report time interval from the 
index tests to the reference 
standard, and any treatment 
administered between. 222 77 1 74 
Identify the article as a study 
of diagnostic 
accuracy(recommend MeSH 
heading 'sensitivity and 
specificity'). 210 90 0 70 
Report clinical and 
demographic characteristics of 
the study population (e.g. age, 
sex, spectrum of presenting 
symptoms, co morbidity, 
current treatments, recruitment 
centers). 208 91 1 69 
Report estimates of 
variability of diagnostic 
accuracy between subgroups 
of participants, readers or 
centers, if done. 166 133 1 55 
 17 
Report the number of 
participants satisfying the 
criteria for inclusion that did 
or did not undergo the index 
tests and/or the reference 
standard; describe why 
participants failed to receive 
either test (a flow diagram is 
strongly recommended). 135 150 15 45 
Report any adverse events 
from performing the index 
tests or the reference 
standard. 131 169 0 44 
Report when study was done, 
including beginning and 
ending dates of recruitment. 122 178 0 41 
Report how indeterminate 
results, missing responses 
and outliers of the index 
tests were handled. 109 190 1 36 
Describe methods for 
calculating test 
reproducibility, if done. 99 190 11 33 
Report estimates of test 
reproducibility, if done. 98 193 9 33 
Describe the number, training 
and expertise of the persons 
executing and reading the 
index tests and the reference 
standard. 85 215 0 28 
Mean adherence (%) to individual STARD criteria
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Table 2. 
CRITERIA GROUP: 
CMR 
before 
STARD 
CMR 
after 
STARD 
 
 
p value 
CCT 
before 
STARD 
CCT 
after 
STARD 
 
 
p value 
 
SPECT 
before 
STARD 
 
SPECT 
after 
STARD 
 
 
p value 
TITLE 1 
Identify the article as a study of diagnostic 
accuracy (recommend MeSH heading 'sensitivity 
and specificity'). 74 52 
 
 
0.0250
3 52 90 
 
 
0.0001 
78 74 
 
 
0.82 
INTRODUCTION 2 
State the research questions or study aims, such as 
estimating diagnostic accuracy or comparing 
accuracy between tests or across participant groups. 100 94 
 
 
 
0.24 94 100 
 
 
 
0.24 94 98 
 
 
 
0.62 
METHODS 
  
  
Participants 3 
Describe the study population: The inclusion and 
exclusion criteria, setting and locations where the 
data were collected. 82 98 
 
 
0.0150
2 72 88 
 
 
0.07 
88 70 
 
 
0.0290
5 
 
4 
Describe participant recruitment: Was recruitment 
based on presenting symptoms, results from 
previous tests, or the fact that the participants had 
received the (evaluated) index tests or the (golden) 
reference standard? 88 96 
 
 
 
 
0.06 94 98 
 
 
 
 
0.99 98 96 
 
 
 
 
0.99 
5 
Describe participant sampling: Was the study 
population a consecutive series of participants 
defined by the selection criteria in items 3 and 4? 
If not, specify how participants were further 
selected. 70 78 
 
 
 
0.49 78 84 
 
 
 
0.39 76 88 
 
 
 
0.19 
6 
Describe data collection: Was data collection 
planned before the index test and reference standard 
were performed (prospective study) or after 
(retrospective study)? 86 98  
 
 
 
0.06 
74 94 
 
 
 
0.0076
008 82 78 
 
 
 
0.8 
Test methods 7 Describe the reference standard and its rationale. 86 98  
 
0.06 84 90 
 
0.55 100 86 
 
0.0130
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1 
 
8 
Describe technical specifications of material and 
methods involved including how and when 
measurements were taken, and/or cite references for 
index tests and reference standard. 98 100 
 
 
 
0.99 98 100 
 
 
 
0.99 100 94 
 
 
 
0.24 
9 
Describe definition of and rationale for the units, 
cut-offs and/or categories of the results of the 
index tests and the reference standard. 84 100 
 
 
 
0.004 96 98 
 
 
 
 0.99 100 94 
 
 
 
0.24 
10 
Describe the number, training and expertise of the 
persons executing and reading the index tests and 
the reference standard. 8 66  
 
 
0.0001 22 26 
 
 
0.81 40 8 
 
 
0.0003 
11 
Describe whether or not the readers of the index 
tests and reference standard were blind (masked) 
to the results of the other test and describe any 
other clinical information available to the 
readers. 64 74 
 
 
 
0.39 
70 90 
 
 
 
0.0150
2 80 80 
 
 
 
1 
Statistical methods 12 
Describe methods for calculating or comparing 
measures of diagnostic accuracy, and the statistical 
methods used to quantify uncertainty (e.g. 95% 
confidence intervals). 72 92  
 
 
 
0.011 
66 90 
 
 
 
0.0046
005 82 92 
 
 
 
0.23 
 13 
Describe methods for calculating test 
reproducibility, if done. 30 34 
 
0.83 
14 46 
 
0.0007 
26 48 
 
0.0250
3 
RESULTS 
  
  
Participants 14 
Report when study was done, including beginning 
and ending dates of recruitment. 30 34 
 
 
0.83 
40 66 
 
 
0.0160
2 32 42 
 
 
0.4 
 15 
Report clinical and demographic characteristics 
of the study population (e.g. age, sex, spectrum of 
presenting symptoms, co morbidity, current 
treatments, recruitment centers). 48 94  
 
 
 
0.0001 
52 74 
 
 
 
0.0250
3 78 70 
 
 
 
0.49 
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16 
Report the number of participants satisfying the 
criteria for inclusion that did or did not undergo the 
index tests and/or the reference standard; describe 
why participants failed to receive either test (a flow 
diagram is strongly recommended). 44 66  
 
 
 
 
0.0250
3 44 60 
 
 
 
 
0.16 
26 30 
 
 
 
 
0.82 
Test results 17 
Report time interval from the index tests to the 
reference standard, and any treatment 
administered between. 70 62 
 
 
0.53 
64 84 
 
 
0.0250
3 88 76 
 
 
0.19 
 
18 
Report distribution of severity of disease (define 
criteria) in those with the target condition; other 
diagnoses in participants without the target 
condition. 72 94  
 
 
 
0.0042
004 80 84 
 
 
 
0.79 
92 90 
 
 
 
0.99 
19 
Report a cross tabulation of the results of the 
index tests (including indeterminate and missing 
results) by the results of the reference standard; 
for continuous results, the distribution of the test 
results by the results of the reference standard. 
 
 
64 
 
 
62 
 
 
 
 
0.99 
 
 
62 90 
 
 
 
 
0.0014
001 80 94 
 
 
 
 
0.07 
20 
Report any adverse events from performing the 
index tests or the reference standard. 58 36 
 
0.0250
3 38 68 
 
0.0034
003 34 28 
 
0.67 
Estimates 21 
Report estimates of diagnostic accuracy and 
measures of statistical uncertainty (e.g. 95% 
confidence intervals). 92 80 
 
 
0.14 70 80 
 
 
0.36 98 96 
 
 
0.99 
 
22 
Report how indeterminate results, missing responses 
and outliers of the index tests were handled. 52 42 
 
 
0.42 
30 50 
 
 
0.0650
7 24 20 
 
 
 0.81 
23 
Report estimates of variability of diagnostic 
accuracy between subgroups of participants, 
readers or centers, if done. 30 50  
 
 
0.06 
40 58 
 
 
0.1 
66 86 
 
 
0.0340
3 
 21 
24 Report estimates of test reproducibility, if done. 22 38 
 
0.12 
18 50 
 
0.0011
001 24 44 
 
0.0560
6 
DISCUSSION 25 
Discuss the clinical applicability of the study 
findings. 94 96 
 
 0.99 92 98 
 
0.36 96 96 
 
1 
Adherence (%) to STARD criteria per imaging modality and timing of publication in relation to STARD statement (p values <0.05 in bold) 
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Table 3. 
  Before STARD After STARD P value 
Adherence to 
STARD (%) 
CMR 65.3 ± 17.3 74.1 ± 10.1 0.003 
CCT 61.6 ± 13.0 79.0 ± 14.3 0.0001 
SPECT 71.7 ± 9.9 71.5 ± 11.8 0.92 
Impact factor at 
time of publication 
CMR 2.4 (1.4; 5.6) 3.7 (2.7; 5.9) 0.01 
CCT 2.4 (1.9; 5.8) 2.8 (2.2; 3.7) 0.92 
SPECT 2.4 (1.8; 4.5) 2.7 (1.3; 3.4) 0.83 
Citation index for 2 
years after 
publication 
CMR 2.0 (0; 8.0) 5.0 (3.0; 23.0) 0.004 
CCT 9.0 (4.0; 26.0) 6.5 (4.0; 28.0) 0.8 
SPECT 
3.0 (1.0; 6.0) 
3.0 (2.0; 6.0) 0.83 
Adherence (%) to STARD, journal impact factor in for the year of publication and number of citations 
for the two years after publication per imaging modality and timing of publication with regards to 
STARD statement publication. P values for adherence are based on one-way ANOVA, and for impact 
factor and citation index on Kruskal-Wallis test; 
 
 
 
FIGURE LEGENDS 
Figure 1: Flow diagram of study selection process 
Figure 2: Reporting quality of diagnostic accuracy studies before and after the introduction of STARD 
criteria in 2003. The left hand panel shows the mean +/- standard deviation of adherence (%) to 
STARD criteria in the 300 studies assessed. The right hand panel shows the predicted adherence (%) to 
STARD criteria applying the multivariable linear regression model which adjusts for impact factor of 
the journal.  
Figure 3: % adherence to STARD for studies from journals of above and below median impact factor. 
Journals of above median impact factor published studies with significantly higher mean adherence to 
STARD (74.1% ±12.2 vs 66.7% ±13.9) when compared to those of below median impact factor 
(p<0.0001) 
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ABSTRACT  
Aims: Diagnostic accuracy studies determine the clinical value of non-invasive cardiac imaging tests. The 
‘Standards for the reporting of diagnostic accuracy studies’ (STARD) were published in 2003 to improve the 
quality of study reporting. We aimed to assess the reporting quality of cardiac computed tomography (CCT), 
single positron emission computed tomography (SPECT) and cardiac magnetic resonance (CMR) diagnostic 
accuracy studies; to evaluate the impact of STARD; and to investigate the relationships between reporting 
quality, journal impact factor and study citation index. 
Methods and Results: We randomly generated 6 groups of 50 diagnostic accuracy studies: ‘CMR 1995-2002’, 
‘CMR 2004-2011’, ‘CCT 1995-2002’, ‘CCT 2004-2011’, ‘SPECT 1995-2002’, and ‘SPECT 2004-2011’. The 
300 studies were double-read by 2 blinded reviewers and reporting quality determined by % adherence to the 25 
STARD criteria. Reporting quality increased from 65.3% before STARD to 74.1% after (p=0.003) in CMR 
studies and from 61.6% to 79.0% (p<0.001) in CCT studies. SPECT studies showed no significant change: 
71.9% before and 71.5% after STARD (p=0.92). Journals advising authors to refer to STARD had significantly 
higher impact factors than those that did not (p=0.03), and journals with above-median impact factors published 
studies of significantly higher reporting quality (p<0.001). Since STARD, citation index has not significantly 
increased (p=0.14) but, after adjustment for impact factor, reporting quality continues to increase by 
approximately 1.5% each year. 
Conclusion: Reporting standards for diagnostic accuracy studies of non-invasive cardiac imaging are at most 
satisfactory and have improved since the introduction of STARD. Adherence to STARD should be mandatory 
for authors of diagnostic accuracy studies. 
 
KEYWORDS 
Diagnostic accuracy, STARD, reporting quality 
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ABBREVIATIONS LIST 
CMR, cardiac magnetic resonance;  
CCT, cardiac computed tomography;  
SPECT, single positron emission computed tomography;  
STARD, Standards for the reporting of diagnostic accuracy studies;  
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INTRODUCTION 
Advanced non-invasive cardiovascular imaging modalities, such as Cardiovascular Magnetic 
Resonance (CMR) imaging, Cardiovascular Computed Tomography (CCT) and Single Positron 
Emission Computed Tomography (SPECT) are increasingly requested clinically. Between 2000 and 
2006, Medicare expenditure on medical imaging increased annually by 17% and, since 1996, mean per 
capita radiation dose has doubled, highlighting the need to avoid unnecessary use of these expensive 
technologies 
(1, 2)
.  
Diagnostic accuracy is an important consideration in determining the cost-effectiveness of an imaging 
test, but often varies amongst different publications. This may reflect the dependence of the results on 
factors such as study design, patient population and technical considerations as well as random 
variability. Insufficient reporting may not allow assessment of the internal and external validity of the 
study findings. Furthermore, over-optimistic diagnostic accuracy results can lead to the premature 
dissemination of imaging tests and consequently to doctors making incorrect management decisions, 
contributing to the significant rise in health care costs.  
In 2003, the Standards for the Reporting of Diagnostic Accuracy Studies (STARD) group published a 
set of 25 criteria with the objective of improving the reporting quality of diagnostic accuracy studies 
(3-
5)
.
 
These criteria allow the reader to identify the potential for bias in the study (internal validity) and to 
evaluate whether the results of the studies can be generalized to a wider population (external validity). 
To date, over 200 journals advise authors to refer to STARD when submitting manuscripts 
(http://www.stard-statement.org/). 
Given the importance of high quality diagnostic test reporting in cardiac patients and the lack of data 
on adherence to the STARD criteria in this field, the aim of this study was to assess the impact of 
STARD by comparing the reporting quality of CCT, SPECT and CMR studies published in the eight 
years before STARD (1995-2002) with those published in the eight years after (2004-2011). 
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METHODS 
Literature Search 
A literature search of the Ovid Medline and EMBASE databases was performed on September 1
st
 
2011. We searched for CCT, SPECT and CMR studies of diagnostic accuracy published before (1995-
2002 inclusive) and after (2004-2011 inclusive) the introduction of the STARD statement in 2003. The 
MeSH terms, corresponding number of identified studies and study groupings are shown in Figure 1. 
 
Selection Criteria 
We included studies that examined the performance of CCT, SPECT or CMR investigations in relation 
to a reference standard. Animal models, reviews, meta-analyses, and studies comparing more than one 
of the CCT, SPECT or CMR modalities against a reference standard were excluded. The identified 
studies were assigned to one of six groups: CCT, SPECT or CMR diagnostic accuracy studies 
published before and after the introduction of STARD in 2003, respectively. In each group, eligible 
studies were numbered and 50 papers selected for analysis using a random number generator 
(Microsoft Excel 2010, Microsoft). Data extraction was performed from each of the selected abstracts. 
Studies that did not meet the inclusion criteria during data extraction were excluded and replaced by 
studies using the random number generator until 50 studies were identified for each of the six groups.  
 
Scoring 
The 300 included studies were blinded to date, authorship, references and journal of publication, and 
read against the criteria of the STARD checklist. Reviewer 1 (E.M.) read all 300 studies; Reviewer 2 
(I.S.) read a random selection of 100 studies, and Reviewer 3 (F.C.) read the remaining 200 studies; 
both reviewers were blinded to the findings of Reviewer 1. Reviewer 4 (S.P.) resolved any disputed 
decisions. All four reviewers were provided with a document explaining the STARD statement and its 
rationale, and were instructed to refer to the STARD statement website (www.stard-statement.org) if 
further clarification on the criteria was required. A total of 7500 STARD items were evaluated within 
the 300 manuscripts. For each STARD criterion, reviewers assigned ‘Yes’ if the manuscript addressed 
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the item appropriately and ‘No’ if it did not. If a criterion was considered not applicable to the study, 
such as in retrospective studies where participant dropout does not occur, the abbreviation ‘NA’ was 
used.  
Impact Factor and Citation Index 
Impact factor in the year of study publication was sourced for each journal from the Thomson Reuters 
Web of Science database. Study Citation Index was calculated by counting the total number of citations 
in the two years following study publication according to Web of Science data. 
Statistics 
Reporting quality was assessed in all studies by calculating the percentage adherence to the STARD 
criteria by dividing the number of agreements with STARD criteria per study by the number of 
possible agreements (25 criteria minus number of criteria considered not applicable for specific study). 
We used the following formula: 
% Adherence =    Number of ‘Yes’       x 100 
 25 – Number of ‘NA’ 
 
Data were examined for normality (median and mean comparison, skewness, kurtosis, the Shapiro 
Wilks test and normal probability plots). Normally distributed data are presented as mean ± standard 
deviation and non-normally distributed data as median (interquartile range). We performed 
independent t-tests or ANOVA for normally distributed data and the Wilcoxon rank-sum test or 
Kruskal-Wallis test for independent samples that were not normally distributed. Chi-square tests were 
used to assess for differences in adherence to all individual STARD criteria. 
A linear regression model was built with adherence (%) to STARD criteria as the outcome and the 
timing of publication with regards to the advent of the STARD criteria in 2003 (before or after 
STARD) as a binary exposure and potential confounders (impact factor, citation index). A spline with a 
knot in the year of STARD publication was introduced to allow for a change in the slope. In all cases 
the significance level was set at p≤0.05 (two-sided). No adjustment for multiple testing was performed 
for pre-specified sub-analyses. All statistical analyses were performed using SAS software (Version 
9.3; SAS Institute Inc., Cary, NC, US). 
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RESULTS 
Study Selection 
As shown in Figure 1, 37 of the initial 300 studies met exclusion criteria and were replaced; 19 were 
animal studies, 8 were meta-analyses or reviews, 6 studies compared more than one imaging modality 
to a reference standard, and 4 studies did not examine diagnostic accuracy. Of the included studies, 167 
evaluated the diagnostic accuracy of CCT, SPECT or CMR with invasive coronary angiography as the 
reference standard; the remaining papers referred to echocardiography (n=38), established CMR, CCT 
or nuclear techniques (n=58), surgical findings, biopsy or histological analysis (n=15), blood tests 
(n=5) or a combination of these investigations (n=17). 8 studies (2.7%) included quantitative 
prognostic data. 
 
Adjudication quality of adherence to STARD 
98.5% of all STARD criteria were evaluated in agreement between the reviewers. Reviewer 4 resolved 
disagreements on 116 of the 7500 (1.5%) assessed items. This high rate of agreement is reflected in an 
unweighted kappa-value of 0.96 (95% confidence interval 0.96 to 0.97). 
 
General reporting quality in non-invasive cardiovascular imaging 
The global adherence to STARD for the 300 studies was 70.6 ± 14.1% and Table 1 shows adherence 
for each STARD criteria separately. STARD criteria were considered 'Not Applicable' in 45 of 7500 
(0.6%) assessed items. The journal impact factor in the year of publication and the citation index for all 
non-invasive cardiovascular imaging studies were 2.8 (1.8; 4.8) and 5.0 (1.0; 11.0), respectively.  
 
Reporting quality according to imaging modality and impact of STARD initiative  
The adherence (%) to STARD criteria across the six groups - CCT, SPECT and CMR before and after 
STARD introduction in 2003 - is presented for each criterion separately (Table 2) and for the combined 
criteria (Table 3).  
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The reporting quality increased from 65.3% to 74.1% (p=0.003) for CMR studies and from 61.6% to 
79.0% (p<0.001) for CCT studies following the introduction of STARD in 2003.  The SPECT studies, 
however, did not show any significant change in reporting quality: 71.9% before and 71.5% after 
STARD (p=0.92). Before the introduction of STARD, CCT studies had significantly poorer reporting 
standards compared to SPECT studies (p=0.001). After the introduction of STARD, CCT reporting 
standards were significantly higher than those of the SPECT studies (p=0.008). All other group 
comparisons did not show any significant difference in reporting quality (p>0.05 for all). 
 
Reporting quality according to journal’s author instructions, impact factors and citation indices 
Since 2003, papers from journals (13/150=8.7%) that advised authors to refer to the STARD guidelines 
demonstrated a trend of higher reporting quality when compared to those that did not (81.2 ±9.3% vs. 
74.3 ± 12.7%, respectively; p=0.06). However, after adjusting for the potential confounder impact 
factor and year of publication, this difference attenuated (p=0.72). 
The impact factor of journals that have adopted STARD was significantly higher than those that have 
not (5.3 (3.7; 5.7) vs. 2.8 (2.1; 4.0), respectively; p=0.03). In journals whose impact factor was equal to 
or above the median, reporting standards were significantly higher than in journals with lower impact 
factors (Figure 3 – p<0.0001). We further investigated whether the impact factor benefited for journals 
that recommended adherence to STARD criteria. To this end, the null hypothesis that the slope or rate 
of change for the impact factor after publication of the STARD publication is the same for journals that 
recommended adherence to STARD criteria compared to those that did not could not be rejected, after 
adjusting for year of publication (p=0.15). 
The citation index for the two years following publication was similar between studies published 
before and after the STARD initiative (7.5 (5.0; 23.0) vs. 4.0 (2.0; 12.0) respectively; p=0.14). 
 
Impact of the STARD initiative on reporting quality when controlling for confounders 
Our multivariable linear regression model allowed for a change in slope by introducing a knot in year 
2003 (STARD publication), which demonstrates the beneficial effect of the STARD criteria on the 
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reporting standards of diagnostic accuracy studies. After controlling for the potential confounder 
impact factor, reporting quality remained unchanged in the 8 years before the introduction of STARD 
(estimate -0.018, p=0.97). However, during the 8 years after the introduction of STARD, the model 
suggests an increase in adherence to STARD criteria by 1.461% (sum of estimates -0.018 +1.479, 
p=0.04) for each calendar year (Figure 2). 
 
 DISCUSSION 
The important findings of this study are firstly that the reporting quality of studies investigating the 
diagnostic accuracy of CCT, SPECT and CMR techniques is at most satisfactory. Furthermore, since 
the publication of the STARD statement in 2003, reporting standards have significantly improved in 
studies of CCT and CMR but not SPECT.  Our assessment also shows that higher reporting quality is 
more strongly associated with a journal’s impact factor than with the journal mentioning the STARD 
criteria in the authors’ instructions, and that reporting quality does not correlate with citation index.  
Whilst similar reviews have been performed in fields such as Endoscopy 
(6)
 and Ophthalmology 
(7, 8)
, 
this is the first investigation into the standards of CCT, SPECT and CMR studies published both before 
and after the STARD statement. An overall average of 70.6% adherence to the STARD criteria 
compares favourably with findings from similar reviews of endoscopy (49%) (6), ophthalmology 
(50.3%) 
(7, 8)
 and gynaecology (55.1%) 
(9)
 journals.  
Previous reviews on the impact of the STARD statement itself have been mixed. Whilst Smidt et al. 
(2006) 
(10)
 reported a significant improvement in reporting standards across a sample of 265 articles 
from 12 medical journals, Wilczynski 
(11)
 did not find any meaningful improvement when comparing 
studies published before and after 2003, nor any difference between articles from journals that had 
adopted the STARD statement and those that had not. In our study, after adjustment for the confounder 
impact factor, the reporting standards measured by adherence to STARD criteria improved by an 
estimated mean of 1.5% per calendar year after the publication of the STARD statement.  
We use adherence to the STARD statement as the sole measure of reporting quality, although the 25 
criteria are not all-encompassing; for example, they make no stipulation of minimum sample size and 
only require a discussion of the clinical applicability of the study findings. However, they are 
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specifically tailored to diagnostic accuracy studies and we believe should be considered the gold 
standard for reporting quality in this study type. Even so, in Hirst & Altman’s  (12) review of 116 
journals, only 19 (16.4%) referred to reporting guidelines in their online instructions for authors, and 
we found that only 8.7% advised reference to STARD when submitting diagnostic accuracy studies. 
Our study suggests that reporting quality improves with this requirement.  
The finding that reporting standards have improved in CCT and CMR studies but not in those of 
SPECT is intriguing. This may be because, prior to STARD, CCT and CMR studies were 
predominantly developmental in nature and have since progressed to the validation phase. SPECT, 
meanwhile, is longer established and its use, together with other nuclear techniques, is declining by 3% 
annually in the United States 
(2)
. One could also speculate that, as CCT and CMR are younger imaging 
modalities, the researchers publishing in these areas are more willing to adapt to new reporting 
guidelines. 
Given the potentially serious consequences of poor diagnostic studies on patient management and 
healthcare costs, reporting standards remain a concern despite the clear improvement seen following 
publication of the STARD statement. The reporting of individual criteria varied from 28-98% , with 
seven criteria addressed in less than 50% of studies. Only 33% of studies made estimations of test 
reproducibility, which echoes that of similar reviews 
(8)
.This is likely attributable to the considerable 
resources required to perform such measurements and many authors choose to publish separate studies 
of reproducibility. However, the ability of a diagnostic test to deliver reproducible results is paramount, 
and every effort should be made to provide or reference such data where feasible. A quantification of 
observers’ training was found in only 28% of studies; this may seem a stringent requirement but, in 
practice, clinicians often consider an observer’s expertise when evaluating their opinion, and so such 
information should be made available to study readers as it informs generalizability of the study 
findings. Only 44% of studies mentioned adverse events; one might presume this reflects the relative 
safety of CCT, SPECT and CMR techniques over their invasive counterparts, but clarification of the 
absence of any complications is still necessary.  
Strategies to further improve reporting standards may include journals not only advising reference to 
the STARD criteria in their author instructions, but making adherence to STARD a mandatory 
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prerequisite to manuscript submission. In addition, the publication of systematic reviews such as this 
may further increase awareness of the STARD criteria and the importance of adhering to them. 
Although the selection of 300 studies constitutes less than 10% of the total identified literature, our 
selection and randomisation process should have ensured a representative sample of diagnostic 
accuracy manuscripts. As we did not adjust for multiple testing, there is a chance of reporting false 
positive findings. However, we pre-specified the assessment of the impact of the STARD 
recommendations on the quality of reporting as our primary hypothesis. We were surprised by the large 
disparity in the number of studies identified before and after 2003, but this could be attributed to the 
increased volume of studies published. Having used “diagnostic accuracy” as a search term, there is 
potential for a selection bias. The decision to include a small number of prognostic studies (n=8) must 
also be justified; the STARD statement refers to diagnostic accuracy studies alone, however, we 
believe the criteria are equally applicable to prognostic studies investigating quantitative outcome 
variables – such as degree of residual mitral regurgitation – where an account of technical 
specifications, statistical models, time intervals, participant recruitment and demographics, dropout and 
outliers remains essential. 
The reporting standards of diagnostic accuracy studies in the field of non-invasive cardiac imaging are 
satisfactory at best and have improved since the introduction of STARD. Those journals that advise 
authors to refer to STARD have significantly higher impact factors, and authors should be encouraged 
that journals of relatively high impact factors publish diagnostic accuracy studies of higher reporting 
quality. To further increase the adherence to the STARD criteria and thereby improve the quality of 
diagnostic accuracy studies, we suggest that more journals incorporate the STARD statement as a 
mandatory component of their submission process. By improving the transparency and completeness of 
study reporting, such measures may expedite the development of non-invasive imaging tests, reduce 
unnecessary expenditure and assist doctors in making evidence-based management decisions. 
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Table 1. 
STARD  
CRITERIA 
Number of studies 
that met criteria 
Number of studies 
that did not meet 
criteria 
Number of studies 
where criteria not 
applicable 
ADHERENCE 
(%) 
(n=300) 
Describe technical 
specifications of material and 
methods involved including 
how and when measurements 
were taken, and/or cite 
references for index tests and 
reference standard. 295 5 0 98 
State the research questions 
or study aims, such as 
estimating diagnostic 
accuracy or comparing 
accuracy between tests or 
across participant groups. 290 10 0 97 
Describe definition of and 
rationale for the units, cut-offs 
and/or categories of the results 
of the index tests and the 
reference standard. 286 14 0 95 
Discuss the clinical 
applicability of the study 
findings. 286 14 0 95 
Describe participant 
recruitment: Was recruitment 
based on presenting 
symptoms, results from 
previous tests, or the fact that 
the participants had received 
the (evaluated) index tests or 
the (golden) reference 
standard? 285 15 0 95 
Describe the reference 
standard and its rationale. 272 28 0 91 
Report estimates of diagnostic 
accuracy and measures of 
statistical uncertainty (e.g. 
95% confidence intervals). 259 41 0 86 
Describe data collection: 
Was data collection planned 
before the index test and 
reference standard were 
performed (prospective 
study) or after (retrospective 
study)? 256 43 1 85 
Report distribution of severity 
of disease (define criteria) in 
those with the target 
condition; other diagnoses in 
participants without the target 
condition. 256 44 0 85 
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Describe the study 
population: The inclusion 
and exclusion criteria, 
setting and locations where 
the data were collected. 249 51 0 83 
Describe methods for 
calculating or comparing 
measures of diagnostic 
accuracy, and the statistical 
methods used to quantify 
uncertainty (e.g. 95% 
confidence intervals). 247 53 0 82 
Describe participant 
sampling: Was the study 
population a consecutive 
series of participants defined 
by the selection criteria in 
items 3 and 4? If not, specify 
how participants were 
further selected. 237 61 2 79 
Describe whether or not the 
readers of the index tests and 
reference standard were blind 
(masked) to the results of the 
other test and describe any 
other clinical information 
available to the readers. 230 68 2 77 
Report a cross tabulation of 
the results of the index tests 
(including indeterminate 
and missing results) by the 
results of the reference 
standard; for continuous 
results, the distribution of 
the test results by the results 
of the reference standard. 226 73 1 75 
Report time interval from the 
index tests to the reference 
standard, and any treatment 
administered between. 222 77 1 74 
Identify the article as a study 
of diagnostic 
accuracy(recommend MeSH 
heading 'sensitivity and 
specificity'). 210 90 0 70 
Report clinical and 
demographic characteristics of 
the study population (e.g. age, 
sex, spectrum of presenting 
symptoms, co morbidity, 
current treatments, recruitment 
centers). 208 91 1 69 
Report estimates of 
variability of diagnostic 
accuracy between subgroups 
of participants, readers or 
centers, if done. 166 133 1 55 
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Report the number of 
participants satisfying the 
criteria for inclusion that did 
or did not undergo the index 
tests and/or the reference 
standard; describe why 
participants failed to receive 
either test (a flow diagram is 
strongly recommended). 135 150 15 45 
Report any adverse events 
from performing the index 
tests or the reference 
standard. 131 169 0 44 
Report when study was done, 
including beginning and 
ending dates of recruitment. 122 178 0 41 
Report how indeterminate 
results, missing responses 
and outliers of the index 
tests were handled. 109 190 1 36 
Describe methods for 
calculating test 
reproducibility, if done. 99 190 11 33 
Report estimates of test 
reproducibility, if done. 98 193 9 33 
Describe the number, training 
and expertise of the persons 
executing and reading the 
index tests and the reference 
standard. 85 215 0 28 
Mean adherence (%) to individual STARD criteria
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Table 2. 
CRITERIA GROUP: 
CMR 
before 
STARD 
CMR 
after 
STARD 
 
 
p value 
CCT 
before 
STARD 
CCT 
after 
STARD 
 
 
p value 
 
SPECT 
before 
STARD 
 
SPECT 
after 
STARD 
 
 
p value 
TITLE 1 
Identify the article as a study of diagnostic 
accuracy (recommend MeSH heading 'sensitivity 
and specificity'). 74 52 
 
 
0.03 52 90 
 
 
0.0001 78 74 
 
 
0.82 
INTRODUCTION 2 
State the research questions or study aims, such as 
estimating diagnostic accuracy or comparing 
accuracy between tests or across participant groups. 100 94 
 
 
 
0.24 94 100 
 
 
 
0.24 94 98 
 
 
 
0.62 
METHODS 
  
  
Participants 3 
Describe the study population: The inclusion and 
exclusion criteria, setting and locations where the 
data were collected. 82 98 
 
 
0.02 72 88 
 
 
0.07 88 70 
 
 
0.05 
 
4 
Describe participant recruitment: Was recruitment 
based on presenting symptoms, results from 
previous tests, or the fact that the participants had 
received the (evaluated) index tests or the (golden) 
reference standard? 88 96 
 
 
 
 
0.06 94 98 
 
 
 
 
0.99 98 96 
 
 
 
 
0.99 
5 
Describe participant sampling: Was the study 
population a consecutive series of participants 
defined by the selection criteria in items 3 and 4? 
If not, specify how participants were further 
selected. 70 78 
 
 
 
0.49 78 84 
 
 
 
0.39 76 88 
 
 
 
0.19 
6 
Describe data collection: Was data collection 
planned before the index test and reference standard 
were performed (prospective study) or after 
(retrospective study)? 86 98  
 
 
 
0.06 74 94 
 
 
 
0.008 82 78 
 
 
 
0.8 
Test methods 7 Describe the reference standard and its rationale. 86 98  
 
0.06 84 90 
 
0.55 100 86 
 
0.01 
 8 
Describe technical specifications of material and 
methods involved including how and when 
measurements were taken, and/or cite references for 
index tests and reference standard. 98 100 
 
 
 98 100 
 
 
 100 94 
 
 
 
 19 
0.99 0.99 0.24 
9 
Describe definition of and rationale for the units, 
cut-offs and/or categories of the results of the 
index tests and the reference standard. 84 100 
 
 
 
0.004 96 98 
 
 
 
 0.99 100 94 
 
 
 
0.24 
10 
Describe the number, training and expertise of the 
persons executing and reading the index tests and 
the reference standard. 8 66  
 
 
0.0001 22 26 
 
 
0.81 40 8 
 
 
0.0003 
11 
Describe whether or not the readers of the index 
tests and reference standard were blind (masked) 
to the results of the other test and describe any 
other clinical information available to the 
readers. 64 74 
 
 
 
0.39 70 90 
 
 
 
0.02 80 80 
 
 
 
1 
Statistical methods 12 
Describe methods for calculating or comparing 
measures of diagnostic accuracy, and the statistical 
methods used to quantify uncertainty (e.g. 95% 
confidence intervals). 72 92  
 
 
 
0.01 66 90 
 
 
 
0.005 82 92 
 
 
 
0.23 
 13 
Describe methods for calculating test 
reproducibility, if done. 30 34 
 
0.83 14 46 
 
0.0007 26 48 
 
0.03 
RESULTS 
  
  
Participants 14 
Report when study was done, including beginning 
and ending dates of recruitment. 30 34 
 
 
0.83 40 66 
 
 
0.02 32 42 
 
 
0.4 
 
15 
Report clinical and demographic characteristics 
of the study population (e.g. age, sex, spectrum of 
presenting symptoms, co morbidity, current 
treatments, recruitment centers). 48 94  
 
 
 
0.0001 52 74 
 
 
 
0.03 78 70 
 
 
 
0.49 
16 
Report the number of participants satisfying the 
criteria for inclusion that did or did not undergo the 
index tests and/or the reference standard; describe 
why participants failed to receive either test (a flow 
diagram is strongly recommended). 44 66  
 
 
 
 
0.03 44 60 
 
 
 
 
0.16 26 30 
 
 
 
 
0.82 
Test results 17 
Report time interval from the index tests to the 
reference standard, and any treatment 
administered between. 70 62 
 
 
0.53 64 84 
 
 
0.03 88 76 
 
 
0.19 
 20 
 
18 
Report distribution of severity of disease (define 
criteria) in those with the target condition; other 
diagnoses in participants without the target 
condition. 72 94  
 
 
 
0.004 80 84 
 
 
 
0.79 92 90 
 
 
 
0.99 
19 
Report a cross tabulation of the results of the 
index tests (including indeterminate and missing 
results) by the results of the reference standard; 
for continuous results, the distribution of the test 
results by the results of the reference standard. 
 
 
64 
 
 
62 
 
 
 
 
0.99 
 
 
62 90 
 
 
 
 
0.001 80 94 
 
 
 
 
0.07 
20 
Report any adverse events from performing the 
index tests or the reference standard. 58 36 
 
0.03 38 68 
 
0.003 34 28 
 
0.67 
Estimates 21 
Report estimates of diagnostic accuracy and 
measures of statistical uncertainty (e.g. 95% 
confidence intervals). 92 80 
 
 
0.14 70 80 
 
 
0.36 98 96 
 
 
0.99 
 
22 
Report how indeterminate results, missing responses 
and outliers of the index tests were handled. 52 42 
 
 
0.42 30 50 
 
 
0.07 24 20 
 
 
 0.81 
23 
Report estimates of variability of diagnostic 
accuracy between subgroups of participants, 
readers or centers, if done. 30 50  
 
 
0.06 40 58 
 
 
0.1 66 86 
 
 
0.03 
24 Report estimates of test reproducibility, if done. 22 38 
 
0.12 18 50 
 
0.001 24 44 
 
0.06 
DISCUSSION 25 
Discuss the clinical applicability of the study 
findings. 94 96 
 
 0.99 92 98 
 
0.36 96 96 
 
1 
Adherence (%) to STARD criteria per imaging modality and timing of publication in relation to STARD statement (p values <0.05 in bold) 
 
 
 21 
 
Table 3. 
  Before STARD After STARD P value 
Adherence to 
STARD (%) 
CMR 65.3 ± 17.3 74.1 ± 10.1 0.003 
CCT 61.6 ± 13.0 79.0 ± 14.3 0.0001 
SPECT 71.7 ± 9.9 71.5 ± 11.8 0.92 
Impact factor at 
time of publication 
CMR 2.4 (1.4; 5.6) 3.7 (2.7; 5.9) 0.01 
CCT 2.4 (1.9; 5.8) 2.8 (2.2; 3.7) 0.92 
SPECT 2.4 (1.8; 4.5) 2.7 (1.3; 3.4) 0.83 
Citation index for 2 
years after 
publication 
CMR 2.0 (0; 8.0) 5.0 (3.0; 23.0) 0.004 
CCT 9.0 (4.0; 26.0) 6.5 (4.0; 28.0) 0.8 
SPECT 
3.0 (1.0; 6.0) 
3.0 (2.0; 6.0) 0.83 
Adherence (%) to STARD, journal impact factor in for the year of publication and number of citations 
for the two years after publication per imaging modality and timing of publication with regards to 
STARD statement publication. P values for adherence are based on one-way ANOVA, and for impact 
factor and citation index on Kruskal-Wallis test; 
 
 
 
FIGURE LEGENDS 
Figure 1: Flow diagram of study selection process 
Figure 2: Reporting quality of diagnostic accuracy studies before and after the introduction of STARD 
criteria in 2003. The left hand panel shows the mean +/- standard deviation of adherence (%) to 
STARD criteria in the 300 studies assessed. The right hand panel shows the predicted adherence (%) to 
STARD criteria applying the multivariable linear regression model which adjusts for impact factor of 
the journal.  
Figure 3: % adherence to STARD for studies from journals of above and below median impact factor. 
Journals of above median impact factor published studies with significantly higher mean adherence to 
STARD (74.1% ±12.2 vs 66.7% ±13.9) when compared to those of below median impact factor 
(p<0.0001) 
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